Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 10/20 | 0.51 |
| ▸ | PPARG | P37231 | 5/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | PLG | P00747 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL184497 | 0.90 | GCK (0.51) | GCKPPARGPPARA | |
| SCHEMBL184498 | 0.88 | GCK (0.63) | GCKPPARGPPARA | |
| SCHEMBL184640 | 0.83 | GCK (0.50) | GCKPPARG | |
| SCHEMBL185010 | 0.83 | GCK (0.48) | GCKPPARGPPARA | |
| SCHEMBL184731 | 0.82 | GCK (0.50) | GCK | |
| SCHEMBL184906 | 0.82 | MMP13 (0.51) | GCKMMP2MMP9F10PRSS1 | |
| SCHEMBL197390 | 0.82 | GCK (0.50) | GCK | |
| SCHEMBL185529 | 0.80 | GCK (0.48) | GCKPPARGPPARA | |
| SCHEMBL184678 | 0.80 | GCK (0.43) | GCKPPARG | |
| SCHEMBL184337 | 0.80 | GCK (0.49) | GCKPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2402327-B1 | Acetamide compounds as glucokinase activators, their process and medicinal applications | IMPETIS BIOSCIENCES LTD (IN) | 2018-03-07 | — | — | EP | disclosed |
| EP-2402327-A1 | Acetamide compounds as glucokinase activators, their process and medicinal applications | Advinus Therapeutics Private Limited (IN) | 2012-01-04 | — | — | EP | disclosed |